Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma
Journal of Allergy and Clinical Immunology · 2024-07 · 154 (1) · 101-110
DOI: 10.1016/j.jaci.2023.09.044 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024-07. Verfasst von Leonard B Bacharier und 14 weiteren Autor:innen. Beteiligte Einrichtung: Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: leonard.bacharier@vumc.org. Hauptthemen laut MEDLINE: Asthma, Eosinophils, Biomarkers, Nitric Oxide. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regeneron Pharmaceuticals Inc, Sanofi US.
Abstract (Originalsprache)
BACKGROUND: Blood eosinophils and fractional exhaled nitric oxide (Feno) are prognostic biomarkers for exacerbations and predict lung function responses to dupilumab in adolescents and adults with asthma. OBJECTIVE: We evaluated the relationship between baseline blood eosinophils and Feno and response to dupilumab in children with asthma. METHODS: Children aged 6 to 11 years with uncontrolled moderate-to-severe asthma (n = 408) were randomized to receive dupilumab 100/200 mg by body weight or volume-matched placebo every 2 weeks for 52 weeks. Annualized exacerbation rate (AER) reduction and least squares mean change in prebronchodilator percent predicted forced expiratory volume in 1 second (ppFEV1) at week 12 were assessed according to cutoff baseline levels for Feno (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: leonard.bacharier@vumc.org.
- NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
- Fundación CIDEA, Buenos Aires, Argentina.
- University of Wisconsin School of Medicine and Public Health, Madison, Wis.
- Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
- Sanofi, Bridgewater, NJ.
Förderung
- Regeneron Pharmaceuticals Inc
- Sanofi US
Zitieren
APA
Bacharier, L. B., Pavord, I. D., Maspero, J. F., Jackson, D. J., Fiocchi, A. G., Mao, X., Jacob-Nara, J. A., Deniz, Y., Laws, E., Mannent, L. P., Amin, N., Akinlade, B., Staudinger, H. W., Lederer, D. J., & Hardin, M. (2024). Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma. Journal of Allergy and Clinical Immunology, 154(1), 101-110. https://doi.org/10.1016/j.jaci.2023.09.044
Vancouver
Bacharier LB, Pavord ID, Maspero JF, Jackson DJ, Fiocchi AG, Mao X, et al. Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma. Journal of Allergy and Clinical Immunology. 2024;154(1):101-110. doi:10.1016/j.jaci.2023.09.044
BibTeX
@article{Bacharier2024,
author = {Bacharier, Leonard B and Pavord, Ian D and Maspero, Jorge F and Jackson, Daniel J and Fiocchi, Alessandro G and Mao, Xuezhou and Jacob-Nara, Juby A and Deniz, Yamo and Laws, Elizabeth and Mannent, Leda P and Amin, Nikhil and Akinlade, Bolanle and Staudinger, Heribert W and Lederer, David J and Hardin, Megan},
title = {Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma},
journal = {Journal of Allergy and Clinical Immunology},
year = {2024},
volume = {154},
number = {1},
pages = {101--110},
doi = {10.1016/j.jaci.2023.09.044}
}
EUVIMED